( July 25, 2024, 2:45 PM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on July 24 said it was “guided . . . by the Supreme Court's recent decision on standing and the FDA's regulation of mifepristone in FDA v Alliance for Hippocratic Medicine. 602 U.S. 367 (2024)” and denied a motion filed by Idaho and other anti-abortion states to intervene in a case involving federal regulations for the abortion drug mifepristone....